Bacteria, Gene Editing and Genetic Engineering

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bacteria

Gene Editing

Genetic Engineering

CRISPR Therapeutics begins natural killer cell cancer tie-up with Nkarta

pharmaphorum

MAY 7, 2021

Gene editing firm CRISPR Therapeutics has announced a collaboration with US biotech Nkarta to develop natural killer (NK) cell therapies for cancer. It’s at the forefront of gene editing although the technology has spawned rivals including Intellia Therapeutics, Caribou Biosciences, Sangamo Therapeutics and Mammoth Biosciences.

Gene Editing

Gene Editing Gene Genetic Engineering DNA

Johns Hopkins Researchers Identify CRISPR Dimmer

The Pharma Data

JANUARY 19, 2021

A naturally occurring system for tuning CRISPR-Cas9 expressing in bacteria, identified in a study published in Cell , could have implications for gene editing therapies as well. In bacteria with unaltered tracr-L, levels of CRISPR-related genes were low. The authors found that tracr-L redirects Cas9 in S.

Bacteria

Bacteria Gene Editing Research RNA

Clinical Research Informer

CRISPR Therapeutics begins natural killer cell cancer tie-up with Nkarta

Johns Hopkins Researchers Identify CRISPR Dimmer

Stay Connected